U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07499037) titled 'Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO' on March 18.
Brief Summary: The standard and most common therapy is anticoagulation with heparin according to activated partial thromboplastin time (aPTT) during extracorporeal membrane oxygenation (ECMO) support. The study will focus on evaluating the efficacy and safety of new anticoagulants on ECMO, namely argatroban and enoxaparin in lower doses controlled according to targeted antiIIa and antiXa markers.
Study Start Date: Jan., 2027
Study Type: INTERVENTIONAL
Condition:
Pneumonia
Heart Failure
Intervention:
DRUG: Low anticoagulation d...